Current Otorhinolaryngology Reports

, Volume 4, Issue 2, pp 76–84 | Cite as

OR Management of Recurrent Respiratory Papilloma

  • Andrew J. Bowen
  • Paul C. BrysonEmail author
Recurrent Respiratory Papilloma (L. Akst, Section Editor)
Part of the following topical collections:
  1. Recurrent Respiratory Papilloma


Surgical management of recurrent respiratory papillomatosis has depended upon surgical removal and debulking of disease to maintain a patent airway and preserve vocal function. Over time, this has evolved from cold instrumentation alone to microscope-guided laser ablation. Powered instrumentation in the form of microdebriders has also come to serve an important role for the rapid removal of exophytic, airway obstructive disease. With this evolving technologic sophistication, the surgical paradigm has progressed from maintaining a patent airway to maintaining vocal function. This chapter will discuss the evolution of surgical management, the considerations for airway management and operative anesthesia, and will finally discuss current adjuvant medical therapies and imaging modalities that seek to limit disease recurrence and enhance detection and surgical management.


Human papilloma virus Laryngeal papillomatosis Laryngeal papilloma RRP Office-based surgery KTP laser 


Compliance with Ethics Guidelines

Conflict of Interest

Dr. Andrew J Bowen and Dr. Paul C. Bryson declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular importance, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    • Carifi M, Napolitano D, Morandi M, Dall’Olio D. Recurrent respiratory papillomatosis: current and future perspectives. Ther Clin Risk Manag. 2015;11:731. Excellent review of current state of thought about RRP and the direction towards better treatment and potential cure.Google Scholar
  2. 2.
    Omland T, Akre H, Vårdal M, Brøndbo K. Epidemiological aspects of recurrent respiratory papillomatosis: a population-based study. Laryngoscope. 2012;122(7):1595–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Cohn AM, Kos JT, Taber LH, Adam E. Recurring laryngeal papillopa. Am J Otolaryngol. 1981;2(2):129–32.CrossRefPubMedGoogle Scholar
  4. 4.
    San Giorgi M, van den Heuvel ER, Tjon Pian Gi REA, Brunings JW, Chirila M, Friedrich G, Golusinski W, Graupp M, Horcasitas Pous RA, Ilmarinen T, Jackowska J, Koelmel JC, Ferran Vilà F, Weichbold V, Wierzbicka M, Dikkers FG. Age of onset of recurrent respiratory papillomatosis: a distribution analysis. Clin Otolaryngol. 2015;. doi: 10.1111/coa.12565.PubMedGoogle Scholar
  5. 5.
    Wilcox LJ, Hull BP, Baldassari CM, Derkay CS. Diagnosis and management of recurrent respiratory papillomatosis. Pediatr Infect Dis J. 2014;33(12):1283–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Taliercio S, Cespedes M, Born H, Ruiz R, Roof S, Amin MR, Branski RC. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling. JAMA Otolaryngol Neck Surg. 2015;141(1):78.CrossRefGoogle Scholar
  7. 7.
    Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope. 2008;118(7):1236–47.CrossRefPubMedGoogle Scholar
  8. 8.
    Syrjänen K, Hakama M, Saarikoski S, Väyrynen M, Yliskoski M, Syrjänen S, Kataja V, Castrén O. Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis. 1990;17(1):15–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope. 2004;114(11(Pt 2 Suppl 104)):1–23.CrossRefPubMedGoogle Scholar
  10. 10.
    Cong Luong T, Scrigni A, Ruvinsky S, Cocciaglia A, Rowensztein H. Papilomatosis respiratoria recurrente Caso clínico. Arch Argent Pediatr. 2015;113(04):e203–6.PubMedGoogle Scholar
  11. 11.
    Fusconi M, Grasso M, Greco A, Gallo A, Campo F, Remacle M, Turchetta R, Pagliuca G, DE Vincentiis M. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir. Acta Otorhinolaryngol Ital. 2014;34(6):375–81.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Zacharisen MC, Conley SF. Recurrent respiratory papillomatosis in children: masquerader of common respiratory diseases. Pediatrics. 2006;118(5):1925–31.CrossRefPubMedGoogle Scholar
  13. 13.
    Derkay CS, Hester RP, Burke B, Carron J, Lawson L. Analysis of a staging assessment system for prediction of surgical interval in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2004;68(12):1493–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Derkay CS, Malis DJ, Zalzal G, Wiatrak BJ, Kashima HK, Coltrera MD. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope. 1998;108(6):935–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Venkatesan NN, Pine HS, Underbrink MP. Recurrent respiratory papillomatosis. Otolaryngol Clin North Am. 2012;45(3):671–94, viii–ix.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Avelino MAG, Zaiden TCDT, Gomes RO. Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis. Braz J Otorhinolaryngol. 2013;79(5):636–42.CrossRefPubMedGoogle Scholar
  17. 17.
    Florian Preuss S, Peter Klussmann J, Jungehulsing M, Edmund Eckel H, Guntinas-Lichius O, Damm M. Long-term results of surgical treatment for recurrent respiratory papillomatosis. Acta Otolaryngol (Stockh). 2007;127(11):1196–201.CrossRefGoogle Scholar
  18. 18.
    Strong MS, Vaughan CW, Cooperband SR, Healy GB, Clemente MA. Recurrent respiratory papillomatosis: management with the CO2 laser. Ann Otol Rhinol Laryngol. 1976;85(4 Pt 1):508–16.CrossRefPubMedGoogle Scholar
  19. 19.
    Yan Y, Olszewski AE, Hoffman MR, Zhuang P, Ford CN, Dailey SH, Jiang JJ. Use of lasers in laryngeal surgery. J Voice. 2010;24(1):102–9.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Xu W, Han D, Hou L, Zhang L, Yu Z, Huang Z. Voice function following CO2 laser microsurgery for precancerous and early-stage glottic carcinoma. Acta Otolaryngol (Stockh). 2007;127(6):637–41.CrossRefGoogle Scholar
  21. 21.
    Roy S, Smith LP. Surgical fires in laser laryngeal surgery: are we safe enough? Otolaryngol Head Neck Surg. 2015;152:67–72.CrossRefPubMedGoogle Scholar
  22. 22.
    Hallmo P, Naess O. Laryngeal papillomatosis with human papillomavirus DNA contracted by a laser surgeon. Eur Arch Oto-Rhino-Laryngol. 1991;248(7):425–7.CrossRefGoogle Scholar
  23. 23.
    Calero L, Brusis T. Laryngeal papillomatosis—first recognition in Germany as an occupational disease in an operating room nurse. Laryngorhinootologie. 2003;82(11):790–3.CrossRefPubMedGoogle Scholar
  24. 24.
    Kashima HK, Kessis T, Mounts P, Shah K. Polymerase chain reaction identification of human papillomavirus DNA in CO2 laser plume from recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg. 1991;104(2):191–5.CrossRefPubMedGoogle Scholar
  25. 25.
    Ilmarinen T, Auvinen E, Hiltunen-Back E, Ranki A, Aaltonen L-M, Pitkäranta A. Transmission of human papillomavirus DNA from patient to surgical masks, gloves and oral mucosa of medical personnel during treatment of laryngeal papillomas and genital warts. Eur Arch Otorhinolaryngol. 2012;269(11):2367–71.CrossRefPubMedGoogle Scholar
  26. 26.
    Dedo HH, Yu KCY. CO2 laser treatment in 244 patients with respiratory papillomas. Laryngoscope. 2001;111(9):1639–44.CrossRefPubMedGoogle Scholar
  27. 27.
    Skoulas IG, Kountakis SE. Endotracheal tube obstruction: a rare complication in laser ablation of recurrent laryngeal papillomas. Ear Nose Throat J. 2003;82(7):504–6.PubMedGoogle Scholar
  28. 28.
    Patel N, Rowe M, Tunkel D. Treatment of recurrent respiratory papillomatosis in children with the microdebrider. Ann Otol Rhinol Laryngol. 2003;112(1):7–10.CrossRefPubMedGoogle Scholar
  29. 29.
    •• Centric A, Hu A, Heman-Ackah YD, Divi V, Sataloff RT. Office-based pulsed-dye laser surgery for laryngeal lesions: a retrospective review. J Voice. 2014;28(2):262.e9–e12. Great retrospective review of PDL surgery in the office setting. Google Scholar
  30. 30.
    Koufman JA, Rees CJ, Frazier WD, Kilpatrick LA, Wright SC, Halum SL, Postma GN. Office-based laryngeal laser surgery: a review of 443 cases using three wavelengths. Otolaryngol Head Neck Surg. 2007;137(1):146–51.CrossRefPubMedGoogle Scholar
  31. 31.
    Kuet M-L, Pitman MJ. Photoangiolytic laser treatment of recurrent respiratory papillomatosis: a scaled assessment. J Voice. 2013;27(1):124–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Kuo CY, Halum SL. Office-based laser surgery of the larynx: cost-effective treatment at the office’s expense. Otolaryngol Head Neck Surg. 2012;146(5):769–73.CrossRefPubMedGoogle Scholar
  33. 33.
    Burns JA, Zeitels SM, Akst LM, Broadhurst MS, Hillman RE, Anderson R. 532 nm pulsed potassium-titanyl-phosphate laser treatment of laryngeal papillomatosis under general anesthesia. Laryngoscope. 2007;117(8):1500–4.CrossRefPubMedGoogle Scholar
  34. 34.
    Maturo SC, Hartnick CJ. Juvenile-onset recurrent respiratory papillomatosis. Adv Otorhinolaryngol. 2012;73:105–8.PubMedGoogle Scholar
  35. 35.
    Pasquale K, Wiatrak B, Woolley A, Lewis L. Microdebrider versus CO2 laser removal of recurrent respiratory papillomas: a prospective analysis. Laryngoscope. 2003;113(1):139–43.CrossRefPubMedGoogle Scholar
  36. 36.
    Kim H-T, Baizhumanova AS. Is recurrent respiratory papillomatosis a manageable or curable disease? Laryngoscope. 2015;. doi: 10.1002/lary.Google Scholar
  37. 37.
    Lei W, Wen W, Su Z, Chai L, Feng X, Liu K, Jiang A, Zhu X. Comparison of intravenous general anaesthesia vs endotracheal intubation in the surgical management of juvenile onset recurrent respiratory papillomatosis. Acta Otolaryngol (Stockh). 2010;130(2):281–5.CrossRefGoogle Scholar
  38. 38.
    McMillan K, Shapshay SM, McGilligan JA, Wang Z, Rebeiz EE. A 585-nanometer pulsed dye laser treatment of laryngeal papillomas: preliminary report. Laryngoscope. 1998;108(7):968–72.CrossRefPubMedGoogle Scholar
  39. 39.
    Valdez TA, McMillan K, Shapshay SM. A new laser treatment for vocal cord papilloma-585-nm pulsed dye. Otolaryngol Head Neck Surg. 2001;124(4):421–5.CrossRefPubMedGoogle Scholar
  40. 40.
    Zeitels SM, Akst LM, Burns JA, Hillman RE, Broadhurst MS, Anderson RR. Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Ann Otol Rhinol Laryngol. 2006;115(9):679–85.CrossRefPubMedGoogle Scholar
  41. 41.
    Zeitels SM, Franco RA, Dailey SH, Burns JA, Hillman RE, Anderson RR. Office-based treatment of glottal dysplasia and papillomatosis with the 585-nm pulsed dye laser and local anesthesia. Ann Otol Rhinol Laryngol. 2004;113(4):265–76.CrossRefPubMedGoogle Scholar
  42. 42.
    Rees CJ, Halum SL, Wijewickrama RC, Koufman JA, Postma GN. Patient tolerance of in-office pulsed dye laser treatments to the upper aerodigestive tract. Otolaryngol Head Neck Surg. 2006;134(6):1023–7.CrossRefPubMedGoogle Scholar
  43. 43.
    Zeitels SM, Kobler JB, Heaton JT, Faquin W. Carbon dioxide laser fiber for laryngeal cancer surgery. Ann Otol Rhinol Laryngol. 2006;115(7):535–41.CrossRefPubMedGoogle Scholar
  44. 44.
    Myer CM, Willging JP, McMurray S, Cotton RT. How i do it head and neck and plastic surgery: a targeted problem and its solution: use of a laryngeal micro resector system. Laryngoscope. 1999;109(7):1165–6.CrossRefPubMedGoogle Scholar
  45. 45.
    El-Bitar MA, Zalzal GH. Powered instrumentation in the treatment of recurrent respiratory papillomatosis: an alternative to the carbon dioxide laser. Arch Otolaryngol Head Neck Surg. 2002;128(4):425–8.CrossRefPubMedGoogle Scholar
  46. 46.
    Holler T, Allegro J, Chadha NK, Hawkes M, Harrison RV, Forte V, Campisi P. Voice outcomes following repeated surgical resection of laryngeal papillomata in children. Otolaryngol Head Neck Surg. 2009;141(4):522–6.CrossRefPubMedGoogle Scholar
  47. 47.
    Schraff S, Derkay CS, Burke B, Lawson L. American Society of Pediatric Otolaryngology Members’ experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Neck Surg. 2004;130(9):1039.CrossRefGoogle Scholar
  48. 48.
    Mortensen M, Woo P. An underreported complication of laryngeal microdebrider: vocal fold web and granuloma: a case report. Laryngoscope. 2009;119(9):1848–50.CrossRefPubMedGoogle Scholar
  49. 49.
    •• Howell RJ, Solowski NL, Belafsky PC, Courey MC, Merati AL, Rosen CA, Weinberger PM, Postma GM. Microdebrider complications in laryngologic and airway surgery: microdebrider complications in laryngology. Laryngoscope. 2014;124(11):2579–82. Demonstrates microdebriders major complication-free track record in the airway. Google Scholar
  50. 50.
    Tasca RA, McCormick M, Clarke RW. British Association of Paediatric Otorhinolaryngology members experience with recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2006;70(7):1183–7.CrossRefPubMedGoogle Scholar
  51. 51.
    • Manickavasagam J, Wu K, Bateman ND. Treatment of paediatric laryngeal papillomas: web survey of British Association of Paediatric Otolaryngologists. J Laryngol Otol. 2013;127(9):917–21. Captures microdebriders emergence as instrument of choice for managing RRP abroad. Google Scholar
  52. 52.
    Novakovic D, Cheng ATL, Cope DH, Brotherton JML. Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study. Sex Health. 2010;7(3):253.CrossRefPubMedGoogle Scholar
  53. 53.
    • Murono S, Nakanishi Y, Tsuji A, Endo K, Kondo S, Wakisaka N, Yoshida H, Yoshizaki T. Trends in the management of recurrent respiratory papillomatosis in Japan. Auris Nasus Larynx. 2015;42(3):218–20. Provides contrast to general trend towards the microdebrider as instrument of choice for managing RRP. Google Scholar
  54. 54.
    Baidoo KK, Kitcher E. Recurrent respiratory papillomatosis: the Korle-Bu experience. Ghana Med J. 2012;46(1):43–5.PubMedPubMedCentralGoogle Scholar
  55. 55.
    Chaturvedi J, Sreenivas V, Hemanth V, Nandakumar R. Management of adult recurrent respiratory papillomatosis with oral acyclovir following micro laryngeal surgery: a case series. Indian J Otolaryngol Head Neck Surg. 2014;66(S1):359–63.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Orji FT, Okorafor IA, Akpeh JO. Experience with recurrent respiratory papillomatosis in a developing country: impact of tracheostomy. World J Surg. 2013;37(2):339–43.CrossRefPubMedGoogle Scholar
  57. 57.
    • Harshad PL, Pujari V, Channappa NM, Anandaswamy TC. Anesthesia management in a child with laryngeal papilloma causing near complete airway obstruction. Saudi J Anaesth. 2015;9(1):86–8. Illustrates well the challenge of using spontaneous ventilation for anesthesia in juvenile RRP. Google Scholar
  58. 58.
    Derkay CS. Task force on recurrent respiratory papillomas: a preliminary report. Arch Otolaryngol Head Neck Surg. 1995;121(12):1386–91.CrossRefPubMedGoogle Scholar
  59. 59.
    Bo L, Wang B, Shu S-Y. Anesthesia management in pediatric patients with laryngeal papillomatosis undergoing suspension laryngoscopic surgery and a review of the literature. Int J Pediatr Otorhinolaryngol. 2011;75(11):1442–5.CrossRefPubMedGoogle Scholar
  60. 60.
    Sims HS, Lertsburapa K. Pneumomediastinum and retroperitoneal air after removal of papillomas with the microdebrider and jet ventilation. J Natl Med Assoc. 2007;99(9):1068–70.PubMedPubMedCentralGoogle Scholar
  61. 61.
    Zhang Z, Chang M, Moreta-Sainz LM. Case report: pulmonary papillomatosis in a patient presenting with cough and hemoptysis. Perm J. 2015;19(3):e125–7.PubMedPubMedCentralGoogle Scholar
  62. 62.
    Thorne MC, Zur KB. Transoral trans-stomal microdebrider excision of tracheal papillomatosis. Laryngoscope. 2009;119(5):964–6.CrossRefPubMedGoogle Scholar
  63. 63.
    Ulualp SO, Ryan MW, Wright ST. Microdebrider removal of tracheal papilloma via tracheostomy in the child with an obliterated larynx. J Laryngol Otol. 2007;121(11):1070–2.CrossRefPubMedGoogle Scholar
  64. 64.
    Xiao Y, Wang J, Han D, Ma L. A case of the intrapulmonary spread of recurrent respiratory papillomatosis with malignant transformation. Am J Med Sci. 2015;350(1):55–7.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    •• Sjogren PP, Sidman JD. Use of the carbon dioxide laser for tracheobronchial lesions in children. JAMA Otolaryngol Neck Surg. 2013;139(3):231. Excellent description on how to use a carbon dioxide and bronchoscope for distally spread RRP. Google Scholar
  66. 66.
    Harris K, Chalhoub M. Tracheal papillomatosis: what do we know so far? Chron Respir Dis. 2011;8(4):233–5.CrossRefPubMedGoogle Scholar
  67. 67.
    •• Yıldırım F, Türk M, Demircan S, Akyürek N, Yurdakul AS. Tracheal papilloma treated with cryotherapy and interferon-α: a case report and review of the literature. Case Rep Pulmonol. 2015:2015;1–5. One of the few reviews in the literature describing what is done for distally spread RRP. Google Scholar
  68. 68.
    Carney AS, Evans AS, Mirza S, Psaltis A. Radiofrequency coblation for treatment of advanced laryngotracheal recurrent respiratory papillomatosis. J Laryngol Otol. 2010;124(5):510–4.CrossRefPubMedGoogle Scholar
  69. 69.
    Karatayli-Ozgursoy S, Bishop JA, Hillel A, Akst L, Best SRA. Risk factors for dysplasia in recurrent respiratory papillomatosis in an adult and pediatric population. Ann Otol Rhinol Laryngol. 2015;141:78–83.Google Scholar
  70. 70.
    Gerein V, Rastorguev E, Gerein J, Draf W, Schirren J. Incidence, age at onset, and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 years experience. Otolaryngol Head Neck Surg. 2005;132(3):392–4.CrossRefPubMedGoogle Scholar
  71. 71.
    Zeitels SM, Lopez-Guerra G, Burns JA, Lutch M, Friedman AM, Hillman RE. Microlaryngoscopic and office-based injection of bevacizumab (Avastin) to enhance 532-nm pulsed KTP laser treatment of glottal papillomatosis. Ann Otol Rhinol Laryngol Suppl. 2009;201:1–13.CrossRefPubMedGoogle Scholar
  72. 72.
    Zeitels SM, Barbu AM, Landau-Zemer T, Lopez-Guerra G, Burns JA, Friedman AD, Freeman MW, Halvorsen Y-D, Hillman RE. Local injection of bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: a prospective study. Ann Otol Rhinol Laryngol. 2011;120(10):627–34.PubMedGoogle Scholar
  73. 73.
    Rogers DJ, Ojha S, Maurer R, Hartnick CJ. Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children. JAMA Otolaryngol Head Neck Surg. 2013;139(5):496–501.CrossRefPubMedGoogle Scholar
  74. 74.
    Maturo S, Hartnick CJ. Use of 532-nm pulsed potassium titanyl phosphate laser and adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children: initial experience. Arch Otolaryngol Head Neck Surg. 2010;136(6):561–5.CrossRefPubMedGoogle Scholar
  75. 75.
    • Sidell DR, Nassar M, Cotton RT, Zeitels SM, de Alarcon A. High-dose sublesional bevacizumab (avastin) for pediatric recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 2014;123(3):214–21. Good discussion on dosage regimens for bevacizumab in children and adults. Google Scholar
  76. 76.
    Dikkers FG. Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir—a prospective study. Eur Arch Oto-Rhino-Laryngol Head Neck Surg. 2006;263(5):440–3.CrossRefGoogle Scholar
  77. 77.
    Correia S, Dionísio J, da Costa JD. Recurrent respiratory papillomatosis of the airway: the experience of an endoscopic unit. Rev Port Pneumol. 2015;21(2):82–9.PubMedGoogle Scholar
  78. 78.
    Ksiazek J, Prager JD, Sun GH, Wood RE, Arjmand EM. Inhaled cidofovir as an adjuvant therapy for recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg. 2011;144(4):639–41.CrossRefPubMedGoogle Scholar
  79. 79.
    Giles BL, Seifert B. CR12/339–Nebulized cidofovir for recurrent respiratory papillomatosis: a case report. Paediatr Respir Rev. 2006;7(Suppl 1):S330.PubMedGoogle Scholar
  80. 80.
    •• Derkay CS, Volsky PG, Rosen CA, Pransky SM, McMurray JS, Chadha NK, Froehlich P. Current use of intralesional cidofovir for recurrent respiratory papillomatosis. Laryngoscope. 2013;123(3):705–12. Paper describes history of cidofovir including current consensus concerning its use and efficacy for RRP.Google Scholar
  81. 81.
    Chadha NK, James A. Adjuvant antiviral therapy for recurrent respiratory papillomatosis. Cochrane Database Syst Rev. 2012;12:CD005053.PubMedGoogle Scholar
  82. 82.
    Clamp PJ, Saunders MW. Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2013;77(3):323–8.CrossRefPubMedGoogle Scholar
  83. 83.
    Imaizumi M, Okano W, Tada Y, Omori K. Surgical treatment of laryngeal papillomatosis using narrow band imaging. Otolaryngol Head Neck Surg. 2012;147(3):522–4.CrossRefPubMedGoogle Scholar
  84. 84.
    Tjon Pian Gi REA, Halmos GB, van Hemel BM, van den Heuvel ER, van der Laan BFAM, van Plaat BEC, van Dikkers FG. Narrow band imaging is a new technique in visualization of recurrent respiratory papillomatosis. Laryngoscope. 2012;122(8):1826–30.CrossRefPubMedGoogle Scholar
  85. 85.
    •• Dippold S, Becker C, Nusseck M, Richter B, Echternach M. Narrow band imaging: a tool for endoscopic examination of patients with laryngeal papillomatosis. Ann Otol Rhinol Laryngol. 124(11):886–92. Great analysis of the reliability of NBI to detect papilloma lesions. Google Scholar
  86. 86.
    • Ochsner MC, Klein AM. The utility of narrow band imaging in the treatment of laryngeal papillomatosis in awake patients. J Voice. 2015;29(3):349–51. Good description of application of NBI for in-office management of RRP. Google Scholar
  87. 87.
    •• Rey Caro DG, Rey Caro EP, Rey Caro EA. Chromoendoscopy associated with endoscopic laryngeal surgery: a new technique for treating recurrent respiratory papillomatosis. J Voice. 2014;28(6):822–29. Describes fascinating new technique for augmenting lesion detection and subtype identification. Google Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Head and Neck Institute, Section of LaryngologyCleveland Clinic Lerner College of MedicineClevelandUSA

Personalised recommendations